* Minerva Neurosciences Inc NERV.OQ NERV.O is expected
to show
no change in quarterly revenue when it reports results
*
* Refinitiv's mean analyst estimate for Minerva
Neurosciences Inc
is for a loss of 77 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $11, above its last closing price
of $5.38.
This summary was machine generated November 3 at 18:51 GMT. All
figures in US dollars unless otherwise stated